Prescription Drug Information and News

Our PacificSource Drug Lists are updated monthly.
Learn more about our PacificSource Drug Lists >  

Our drug lists are available in a searchable online format. Find a Drug >   

Preferred Drug List (PDL) Changes

January 2018. The following changes to the drug list are effective January 22, 2018:

Formulary Additions

  • Vigabatrin Powder Pack 500 mg add Tier 1 with preauthorization
  • Adapalene-Benzoyl Peroxide Gel 0.1-2.5% add Tier 1 
  • Prasugrel tablet add Tier 1 
  • Estradiol, Yuvafem Vaginal tablet add Tier 1 
  • Zytiga add Tier 3, SP, with preauthorization 
  • Pertzye add Tier 3 with medical necessity preauthorization
  • Tremfya add Tier 3, SP, medical necessity preauthorization, and quantity limit
  • Desvenlafaxine succinate ER 25mg tablet add Tier 1 with quantity limit 

Preauthorization Update

  • Fluticasone-Salmeterol Aerosol Powder Inhaler remove medical necessity preauthorization 

See the PacificSource Drug Lists page for the current drug list.

December 2017. The following changes to the drug list are effective December 22, 2017:

Formulary Additions

  • Moxifloxacin 0.5% ophthalmic solution add Tier 1
  • Mesalamine 1.2 gm delayed release tablet add Tier 1 with quantity limit
  • Testosterone transdermal solution add Tier 1 with preauthorization
  • Doxycycline Hyclate delayed release tablet add Tier 1 with preauthorization
  • Doryx add Tier 3 with preauthorization
  • Cotempla XR-ODT add Tier 3 with medical necessity preauthorization
  • Duzallo add Tier 3 with medical necessity preauthorization
  • Bevyxxa add Tier 3 with medical necessity preauthorization
  • Gocovri add Tier 3 with medical necessity preauthorization
  • Endari add Tier 3 with quantity limit and step therapy

Tier update

  • Vigamox 0.5% ophthalmic solution change Tier 2 to Tier 3
  • Lialda change Tier 2 to Tier 3

Preauthorization update

  • Azasan, Amrix, Veregen 15% ointment, Flector patch, Zyclara, Zyclara Pump, Doxycycline Hyclate delayed release tablet add medical necessity preauthorization

Step Therapy update

  • Relpax (Eletriptan) add step therapy

See the PacificSource Drug Lists page for the current drug list.

State-based Drug List (ID, MT, OR) Changes

January: All States

January 2018. The following changes to the drug list are effective January 22, 2018:  

Formulary Addition

  • Vigabatrin Powder Pack 500 mg add Tier 4 with preauthorization
  • Adapalene-Benzoyl Peroxide Gel 0.1-2.5% add Tier 1 
  • Prasugrel tablet add Tier 1
  • Desvenlafaxine succinate ER 25 mg tablet add Tier 1 with step therapy
  • Zytiga add Tier 4, SP with preauthorization
  • Fluticasone-Salmeterol Aerosol Powder Inhaler add Tier 1

Removed from Formulary

  • Sabril packet; consider vigabatrin powder packet 

See the PacificSource Drug Lists page for the current drug list. 

January: All States

January 2018. The following changes to the drug list are effective January 1, 2018:

Formulary Addition

The following medications will be added to your plan’s list of covered drugs (formulary) and will be changing from medical coverage to prescription coverage. 

  • Mononine, Koate-DVI, Kogenate FS, Kogenate FS Bio-Set, Helixate FS, Monoclate-P, Humate-P, Hemofil M, Advate, Alphanate/VWF, NovoSeven RT, Xyntha, Xyntha Solofuse, AlphaNine SD, Corifact, Rixubis, Tretten, Alprolix, Eloctate, Obizur, Feiba, Novoeight, Ixinity, Nuwiq, Adynovate, Idelvion, Kovaltry, Wilate, Afstyla, Vonvendi, Benefix, Koate 
  • Cinryze, Berinert, Ruconest

See the PacificSource Drug Lists page for the current drug list. 

December: All States

December 2017. The following changes to the drug list are effective December 22, 2017:  

Formulary Addition

  • Atomoxetine add Tier 1 with quantity limit and stimulant preauthorization
  • Eletriptan add Tier 1 with quantity limit and step therapy
  • Moxifloxacin 0.55 solution add Tier 1
  • Olopatadine 0.2% solution add Tier 1
  • Mesalamine delayed release tablet add Tier 1 with quantity limit
  • Buprenorphine patch add Tier 1 with quantity limit and step therapy
  • Testosterone transdermal solution add Tier 1 with preauthorization
  • Nerlynx add Tier 4, SP with quantity limit and preauthorization
  • Idhifa add Tier 4, SP with quantity limit and preauthorization
  • Tyzeka add Tier 3 with medical necessity preauthorization
  • Otovel otic solution add Tier 3 with medical necessity preauthorization 
  • Endari add Tier 3 with quantity limit and step therapy

Step Therapy update

  • Dutasteride remove step therapy

See the PacificSource Drug Lists page for the current drug list. 

Non-FDA Approved Compounding Agents

A compounded medication is when a pharmacist combines multiple ingredients together. Compounded claims often use what we called "bulk powders." These powders act as a mixing agent/congealing agent to hold the finished product together. These ingredients may not always be approved by the Food and Drug Administration (FDA), thus may not have been reviewed for safety and efficacy. To ensure you are taking medications proven to be safe and effective, beginning August 1, 2017, the non-FDA approved ingredients will be removed from coverage on your plan.

Examples of common non-FDA approved agents:

  • Cellulose (bulk) powder
  • Alcohol, usp 95%
  • Cream base
  • Fatty acid base
  • Gelatin capsules (empty)
  • Hypromellose (bulk) powder
  • Hormone cream base
  • Propylene glycol liquid
  • Thyroid powder
  • Silica gel
  • Stevia (bulk) powder
  • Vitamin E acetate (bulk) liquid

See the non-FDA approved bulk powder agents for the full list >

“Partial Fill” Lets a Patient Test a New Prescription

As you know, some drugs not only have a high cost, but have side effects that make them hard to tolerate for long-term use. Beginning February 22, 2016, these medications will be dispensed in a limited amount, on the first fill only, for half the normal copay. This “partial fill” will act as a trial period to see if the patient is able to successfully take the drug. 

A week into the first fill, a Caremark Specialty Care Team pharmacist or nurse will contact the patient. They will check on side effects and see if the patient was able to tolerate the drug. The Care Team will also answer questions and concerns about the treatment. If the trial period is a success, the patient will continue the drug. After this initial trial, all future fills will be for the full amount. 

On our drug lists, partial-fill drugs are identified by “Partial Fill” in the Restrictions column.

Partial-fill drugs include:

  • Afinitor
  • Bosulif
  • Erivedge
  • Gleevec
  • Inlyta
 
  • Jakafi
  • Nexavar
  • Odomzo
  • Sprycel
  • Sutent
 
  • Tafinlar
  • Tarceva
  • Targretin
  • Tasigna
  • Votrient
 
  • Xalkori
  • Xtandi
  • Zolinza
  • Zykadia
  • Zytiga
 

Preauthorization and Step Therapy Drug Lists with Criteria

Our Preauthorization Policies and Step Therapy Policies documents contain lists of drugs that require preauthorization or that are Step Therapy drugs, as well as their criteria. These two documents replace the one-page "PDL/VDL Preauthorization and Step Therapy Drug Lists" document. You may also use Preauthorization Policies to access our coverage rules for compound medications.

Flu and Pertussis Vaccination Coverage

Our flu vaccination page now includes information about your coverage for whooping cough (pertussis), as well as seasonal flu vaccination and general information.

Consumer Updates from the FDA

Quick Links

PacificSource Drug Lists—our comprehensive drug list page

Preventive Drug List

Incentive Drug List

Prescription drug claim form

Prescription Drug Preauthorization Request (Fax)

InTouch for Members

Are you a Medicare or Medicaid member?

If so, we have a website just for you!

Cool Tools for Managing Your Rx

On the CVS Caremark® website, you'll find tools to help you track pharmacy expenses, save on drug costs, manage your prescriptions, and more. Register by using the member ID number and group code on your ID card. To start, visit Caremark.com.

Why Choose Generics?

Generic prescription medicines are safe, effective, and a good value. Save money by using them instead of brand name drugs whenever possible.

Questions?

Contact our Pharmacy Services Department:

  • Phone: (541) 225-3784
  • Toll-free: (844) 877-4803
  • Email: Use our online Contact Us form
Last updated 12/20/2017